References
- Al-Maaieh A, Flanagan DR. Salt and co-solvent effect on ionic drug loading into microspheres using an O/W method. J Contr Rel 2001; 70: 169–181
- Anderson A, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5–24
- Bhanji NH, Chouinard G, Margolese HC. A review of compliance, depot intramuscular antipsychotics and the new long acting injectable atypical antipsychotic risperidone in schizophrenia. Eur Neuropharmacol 2004; 14: 87–92
- Dinarvand R, Moghadam SH, Sheikhi A, Atyabi F. Effect of surfactant HLB and different formulation variables on the properties of poly-D, L-lactide microspheres of naltrexone prepared by double emulsion technique. J Microencapsulation 2005; 22: 139–151
- Dong CM, Guo YZ, Qiu KY, Gu ZW, Feng XD. In vitro degradation and controlled release behavior of D, L-PLGA50 and PCL-b-D, L-PLGA50 copolymer microspheres. J Contr Rel 2005; 107: 53–64
- Gilbert PL, Harris ML, McAdams LA, Jaste DV. Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Arch Gen Psychiatry 1995; 52: 173–188
- Jiang GE, Thanoo BC, Deluca P. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres. Pharm Dev Tech 2002; 7: 391–399
- Johnson DA. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia. J Clin Psychiatry 1984; 45: 13–21
- Keith S. Advances in psychotropic formulations. Prog Neuro-Psychopharmacol Biol Psychiatry 2006; 30: 996–1008
- Kelleher JP, Centorrino F, Albert MJ, Baldessarini RJ. Advances in atypical antipsychotics for the treatment of schizophrenia: New formulations and new agents. CNS Drugs 2002; 16: 249–261
- Lacro JP, Dunn LB, Dolder CR, Lecband SG, Jaste DV. Prevalence of risk factors for medications non adherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry 2002; 63: 892–909
- Littrell K, Littrelle SH. Therapeutic efficacy of olanzapine. J Am Psych Nurses Assoc 1997; 3: S-8–S-12
- MacCormack PL, Wiseman LR. Olanzapine: A review of its use in the management of bipolar I disorder. Drugs 2004; 64: 2709–2726
- Misdrahi PM, Llorca C, Lancon FJ, Bayle J. Compliance in schizophrenia: Predictive factors, therapeutical considerations and research implications. Encephale 2002; 28: 266–272
- Nose M, Barbui C, Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 2003; 33: 1149–1160
- Park TG. Degradation of poly (lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16: 1123–1130
- Yamaguchi K, Anderson JM. In vivo compatability of Medisorb 65/35 D-L-lactide/glycolide copolymer microspheres. J Contr Rel 1993; 24: 81–93